Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
Marijuana Freedom and Opportunity Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2020 · fourth_quarter · Q4
FDA guidance on CBD enforcement discretion
FY2021 Approps (Provisions related to patient safety, product regulations, and FDA enforcement)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Medical Marijuana Research Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
Medical Cannabis Research Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
Cannabidiol and Marihuana Research Expansion Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
SAFE Banking Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
SAFE Banking Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
HR 1595 - Secure and Fair Enforcement Banking Act of 2019 or the SAFE Banking Act of 2019
SAFE Banking Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
HR 1595 - Secure and Fair Enforcement Banking Act of 2019 or the SAFE Banking Act of 2019
SAFE Banking Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Consolidated Appropriations Act, 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
2019 Consolidated Appropriations Act (H.R. 648) - Sections 536 & 537's impact on other agencies
Consolidated Appropriations Act, 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
2019 Consolidated Appropriations Act (H.R. 648 - Sections 536 & 537's impact on other agencies; FY2020 Omnibus Appropriations Bill - Provisions related to patient safety, product regulations, and FDA enforcement
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Senate: S. 3042 - Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Senate: S. 3042 - Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Senate: S. 3042 - Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Senate: S. 3042 - Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
2020 · third_quarter · Q3
FDA guidance on CBD enforcement discretion
FY2021 Approps/2018 Farm bill (Provisions related to patient safety, product regulations, and FDA enforcement)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2020 · second_quarter · Q2
Cannabis/CBD Research; Covid crisis prep/CLSA organized
FY2021 Approps/2018 Farm bill (Provisions related to patient safety, product regulations, and FDA enforcement)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2020 · first_quarter · Q1
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · fourth_quarter · 4A
HR 1595 - Secure and Fair Enforcement Banking Act of 2019 or the SAFE Banking Act of 2019
Filing targets: SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · fourth_quarter · Q4
HR 1595 - Secure and Fair Enforcement Banking Act of 2019 or the SAFE Banking Act of 2019
Filing targets: SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · third_quarter · 3A
FY2020 Omnibus Appropriations Bill - Issues related to patient safety, product regulations, and FDA enforcement; FDA regulation of cannabidiol in medicines and consumer products
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · third_quarter · Q3
FY2020 Omnibus Appropriations Bill - Issues related to patient safety, product regulations, and FDA enforcement; FDA regulation of cannabidiol in medicines and consumer products
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · second_quarter · Q2
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
2019 Consolidated Appropriations Act (H.R. 648) - Sections 536 & 537's impact on other agencies
FDA regulation of cannabidiol in medicines and consumer products
Filing targets: Agriculture, Dept of (USDA), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · first_quarter · Q1
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
2019 Consolidated Appropriations Act (H.R. 648 - Sections 536 & 537's impact on other agencies; FY2020 Omnibus Appropriations Bill - Provisions related to patient safety, product regulations, and FDA enforcement
Filing targets: Agriculture, Dept of (USDA), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2018 · fourth_quarter · 4A
Senate: S. 3042 - Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2018 · fourth_quarter · Q4
Senate: S. 3042 - Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE